|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US20050054682A1
(en)
*
|
1996-01-04 |
2005-03-10 |
Phillips Jeffrey O. |
Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
|
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
DE19850309A1
(de)
*
|
1998-10-30 |
2000-05-04 |
Lohmann Therapie Syst Lts |
Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
|
|
ES2168043B1
(es)
*
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
|
AU2001232020A1
(en)
*
|
2000-02-09 |
2001-08-20 |
West Pharmaceutical Services Drug Delivery And Clinical Research Centre Limited |
Floating drug delivery composition
|
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
WO2002026210A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Proton pump inhibitor formulation
|
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
|
US7067148B2
(en)
|
2001-02-15 |
2006-06-27 |
King Pharmaceutical Research & Development, Inc. |
Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
|
|
DE10111780B8
(de)
*
|
2001-03-13 |
2005-02-10 |
Isaak Dr. Abramov |
Brausetablette, Pille oder Dragee, sowie das Verfahren zu ihrer Herstellung
|
|
US20030198671A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique plasma AUC properties
|
|
US7101569B2
(en)
|
2001-08-14 |
2006-09-05 |
Franz G Andrew |
Methods of administering levothyroxine pharmaceutical compositions
|
|
US20030171436A1
(en)
*
|
2001-10-29 |
2003-09-11 |
Franz G. Andrew |
Levothyroxine compositions having unique triiodothyronine Tmax properties
|
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
|
WO2004056336A2
(en)
*
|
2002-12-20 |
2004-07-08 |
Ranbaxy Laboratories Limited |
Controlled release, multiple unit drug delivery systems
|
|
CA2520660C
(en)
*
|
2003-03-28 |
2013-08-20 |
Sigmoid Biotechnologies Limited |
Solid oral dosage form containing seamless microcapsules
|
|
US7314640B2
(en)
*
|
2003-07-11 |
2008-01-01 |
Mongkol Sriwongjanya |
Formulation and process for drug loaded cores
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
TW200533391A
(en)
|
2004-03-25 |
2005-10-16 |
Sun Pharmaceutical Ind Ltd |
Gastric retention drug delivery system
|
|
CA2579767A1
(en)
*
|
2004-04-30 |
2005-11-10 |
Astellas Pharma Inc. |
Oral pharmaceutical composition in timed-release particle form and fast-disintegrating tablets containing this composition
|
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
EP2444071A1
(en)
*
|
2004-09-27 |
2012-04-25 |
Sigmoid Pharma Limited |
Minicapsule formulations
|
|
GB0427455D0
(en)
*
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
|
US7803817B2
(en)
*
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
|
US7981908B2
(en)
*
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
|
KR100674622B1
(ko)
*
|
2005-11-04 |
2007-01-29 |
재단법인 포항산업과학연구원 |
연료전지 발전시스템
|
|
FR2902337B1
(fr)
*
|
2005-12-02 |
2010-09-17 |
Vacher Dominique |
Comprimes a liberation immediate et leur production
|
|
AU2007266574A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
|
PL2046334T3
(pl)
*
|
2006-07-25 |
2015-02-27 |
Vecta Ltd |
Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
|
|
CA2661172A1
(en)
|
2006-09-04 |
2008-05-29 |
Panacea Biotec Limited |
Programmable buoyant delivery technology
|
|
WO2008067037A2
(en)
*
|
2006-10-05 |
2008-06-05 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
EP2079456B1
(en)
|
2007-04-04 |
2012-12-05 |
Sigmoid Pharma Limited |
Pharmaceutical cyclosporin compositions
|
|
EP2586428B1
(en)
*
|
2007-04-26 |
2023-11-08 |
Sublimity Therapeutics Limited |
Manufacture of multiple minicapsules
|
|
CA2685591A1
(en)
*
|
2007-05-01 |
2008-11-06 |
Sigmoid Pharma Limited |
Pharmaceutical nimodipine compositions
|
|
HUP0700469A2
(en)
*
|
2007-07-09 |
2009-04-28 |
Richter Gedeon Nyrt |
Floating pharmaceutical composition of sustained release containing metronidazol
|
|
JP2011515438A
(ja)
*
|
2008-03-28 |
2011-05-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
酸ペレットの製造方法
|
|
ES2649112T3
(es)
|
2009-05-18 |
2018-01-10 |
Sigmoid Pharma Limited |
Composición que comprende gotas de aceite
|
|
FR2945947B1
(fr)
*
|
2009-05-29 |
2011-07-29 |
Flamel Tech Sa |
Compositions pharmaceutiques flottantes a liberation controlee
|
|
CN107582526A
(zh)
|
2009-08-12 |
2018-01-16 |
希格默伊德药业有限公司 |
包含聚合物基质和油相的免疫调节组合物
|
|
FR2949061B1
(fr)
*
|
2009-08-12 |
2013-04-19 |
Debregeas Et Associes Pharma |
Microgranules flottants
|
|
GB2481005B
(en)
*
|
2010-06-07 |
2012-08-08 |
Cosmetic Warriors Ltd |
Surfactant product comprising first and second effervescent materials
|
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
|
WO2014191806A2
(en)
*
|
2013-05-02 |
2014-12-04 |
Effrx Pharmaceuticals Sa |
Effervescent formulations that deliver particles which float in the stomach
|
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
|
EP3881829A1
(en)
|
2014-11-07 |
2021-09-22 |
Sublimity Therapeutics Limited |
Compositions comprising cyclosporin
|
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
KR20170003414A
(ko)
*
|
2015-06-30 |
2017-01-09 |
(주)아모레퍼시픽 |
속붕해형 과립환 모발 세정용 조성물
|
|
EP3167879A1
(en)
*
|
2015-11-10 |
2017-05-17 |
Evonik Technochemie GmbH |
Gastric retention active delivery systems
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
WO2025235402A1
(en)
|
2024-05-07 |
2025-11-13 |
Herbalife International Of America, Inc. |
Compositions and methods for effervescent systems with improved stability
|